Latest news

We're delighted to hear that we have once again been awarded an AMRC (Association of Medical Research Charities) Best Practice certificate in the most recent Peer Review Audit 2015.

Scientists at Ulster University are currently working on an exciting new strategy for the fight against pancreatic cancer. The team has made a major breakthrough in the early stages of developing a potential new, minimally invasive treatment, activated by harmless sound waves, also known as ultrasound.

The Scottish Government’s Chief Scientist Office (CSO), Pancreatic Cancer Scotland and Pancreatic Cancer UK are today announcing that for the first time, they will co-fund almost £500,000 of pancreatic cancer research in Scotland.

New data released today (Tuesday, 10th November) shows that nearly half (45 per cent) of pancreatic cancer cases in 2013 were diagnosed as a result of an emergency presentation at hospital. This is more than double the average rate of 20 per cent for all other cancer types.

We are outraged that as of today, (Wednesday 4th November), the life-extending drug Abraxane is no longer available to newly eligible patients with advanced pancreatic cancer in England through the Cancer Drugs Fund (CDF).